Rosiglitazone in Treating Patients With Pituitary Tumors
NCT00616642
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
low patient recruitment
Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG:
rosiglitazone maleate
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
[object Object]